Breaking News

Thermo Fisher Scientific to Showcase Global Innovation at DCAT Week 2022

Supply chain for cell and gene therapies, early-stage process development, steriles, product development & biologics capabilities.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Thermo Fisher Scientific will highlight its recent investments and innovation across its global pharma services network from development to commercial at DCAT Week in New york City.   Supply Chain for Cell and Gene Therapies This year, Thermo Fisher will open one of the largest viral vector sites in North America. The nearly 300,000-square-foot facility in Plainville, MA, will extend the company’s global commercial viral vector network to six sites.    Later this year, Thermo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters